Yamanouchi Pharmaceutical Company Ltd.

Toshimitsu Konno

Hiroshi Maeda

Hiroitsu Kawata

Masayoshi Aruga

Shunji Hasumi

Ken Iwai

Tadayoshi Ohmura

Yutaka Konno

Jun Sekino

Akira Okada

Go Ohtani

Mitsugu Kobayashi

Seiki Tashiro

A lyophilized pharmaceutical composition comprised of a neocarzinostatin derivative having the formula (SMA)-(NCS)-(SMA), is made by a method including dissolving the neocarzinostatin derivative and stabilizing agent comprising at least one saccharide selected from the group consisting of monosaccharides, disaccharides and dextran in an aqueous buffer solution having a pH ranging from about 7.5 to about 9.5, the stabilizing agent being present in an amount by weight (titer) which is at least equal to that of the neocarzinostatin derivative, to provide a solution; adjusting the pH of the solution to provide a pH-adjusted solution having a pH of about 8.0.+-.0.5; sterilizing the pH-adjusted solution by filtration to provide a sterilized solution; and lyophilizing the sterilized solution.

Lyophilized pharmaceutical composition of neocarzinostatin derivative

An oily composition of aclarubicin or aclarubicin hydrochloride comprising aclarubicin or aclarubicin hydrochloride; at least one fatty acid selected from saturated medium chain fatty acids, unsaturated medium chain fatty acids and unsaturated long chain fatty acids; and at least one fats and oils selected from iodized oils and vegetable oils.

Oily composition of aclarubicin or hydrochloride thereof

An oily composition of an antitumor drug comprising at least one sparingly oil soluble or water-soluble antitumor drug, at least one fat or oil, and at least one solubilizing adjuvant in an oily vehicle selected from the group consisting of crown ether, lecithin, polyethylene glycol, propylene glycol, vitamin E, polyoxyethylene alkylether, and sucrose esters of fatty acids.

Oily compositions of antitumor drugs

Growing community of inventors

Kumamoto, Japan

Toshimitsu Konno